---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039594"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2024-10-07T23:59:59+00:00"
generated_at: "2026-05-30T19:16:44.544432+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics issues 118,700 shares on conversion of $474,793 in debentures at $4.00/share

## Summary
- Holders of $474,793 in convertible debentures converted at $4.00/share; 118,700 restricted shares issued.
- Outstanding common shares increased from 1,301,978 to 1,420,678 as a result.
- Conversion exempt from registration under Section 4(a)(2); holders are executive-officer-controlled accredited investors.

## SEC filing metadata
- accession: 0001493152-24-039594
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2024-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315224039594/0001493152-24-039594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315224039594/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039594
- JSON: https://secwatch.observer/filing/0001493152-24-039594.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039594.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.